Skip to main content

Table 1 Demographic data of study population

From: Myocardial blood flow under general anaesthesia with sevoflurane in type 2 diabetic patients: a pilot study

 

Controls (N = 8)

Diabetics (N = 6)

Age, years (range)

44 (28 – 59)

57 (42 – 71)*

BMI, kg/m2

25.7 ± 3.4

30.7 ± 9.4

Duration of diabetes (year)

-

7.7 ± 5

Fasting blood glucose (mmol/l)

4.9 ± 0.4

8.5 ± 1.5*

HbA1c (%)

5.4 ± 0.2

6.8 ± 0.8*

Total cholesterol (mmol/l)

5.1 ± 0.8

3.7 ± 0.3*

LDL cholesterol (mmol/l)

3.1 ± 0.7

1.8 ± 0.3*

HDL cholesterol (mmol/l)

1.3 ± 0.5

1.2 ± 0.4

Triglycerides (mmol/l)

1.4 ± 0.8

2.5 ± 2.9

Creatinine (μmol/l)

83 ± 12

69 ± 10

Urea (mmol/l)

5.5 ± 0.8

5.0 ± 0.9

Oral antidiabetic therapy (nr of patients)

  

 Metformin

 

4

 Glimepiride

 

3

 Exenatide

 

1

 Gliclazide

 

1

 Liraglutide

 

1

 Pioglitazone

 

1

  1. BMI: body mass index; LDL: low-density lipoprotein; HDL: high-density lipoprotein. Data are represented as mean ± SD unless indicated otherwise; Mann–Whitney U test, * p < 0.05.